In the initial stages of capillary formation (angiogenesis) microvascu
lar endothelial cells of preexisting blood vessels locally degrade the
underlying basal lamina and invade into the stroma of the tissue to b
e vascularized. A consistent body of experimental evidence has shown t
hat this process requires a wide array of dedradative enzymes. Compone
nts of the plasminogen activator (PA)-plasmin system and of the matrix
metalloproteinase (MMP) family play important roles. PAs trigger a pr
oteinase cascade that results is the generation of high local concentr
ations of plasmin and active MMPs. This increase in proteolytic activi
ty has three major consequences: it permits endothelial cell degradati
on and invasion of the vessel basal lamina, generates extracellular ma
trix (ECM) degradation products that are chemotactic for endothelial c
ells, and activates and mobilizes growth factors localized in the ECM.
In addition, urokinase-type PA modulates some endothelial cell functi
ons, including proliferation and migration, with a mechanism independe
nt of proteolytic activity. PA and MMP activities are modulated in end
othelial cells by complex mechanisms, including transcriptional regula
tion by a variety of growth factors and cytokines with angiogenic acti
vity, extracellular control of the proteolytic activities by tissue in
hibitors, and interaction with binding sites on the cell membrane and
ECM.